Division of Gynecologic Oncology, New England Trophoblastic Disease Center, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA 02115, USA.
Hematol Oncol Clin North Am. 2012 Feb;26(1):111-31. doi: 10.1016/j.hoc.2011.10.007. Epub 2011 Nov 21.
Gestational trophoblastic neoplasms are malignant lesions that arise from placental villous and extravillous trophoblast. Four clinicopathologic conditions make up this entity: invasive mole (IM), choriocarcinoma (CCA), placental-site trophoblastic tumor (PSTT), and epithelioid trophoblastic tumor (ETT). IM and CCA, which make up the majority of these tumors, are highly responsive to chemotherapy with an overall cure rate exceeding 90%, making it usually possible to achieve cure while preserving reproductive function. PSTT and ETT, which rarely occur, are relatively resistant to chemotherapy, making surgery the primary treatment modality, chemotherapy being used only when the disease has metastasized.
滋养细胞肿瘤是来源于胎盘绒毛和绒毛外滋养细胞的恶性病变。四种临床病理情况构成了这一实体:侵袭性葡萄胎(IM)、绒毛膜癌(CCA)、胎盘部位滋养细胞肿瘤(PSTT)和上皮样滋养细胞肿瘤(ETT)。IM 和 CCA 构成了这些肿瘤的大多数,对化疗高度敏感,总体治愈率超过 90%,通常可以在保留生殖功能的同时实现治愈。很少发生的 PSTT 和 ETT 对化疗相对耐药,因此手术是主要的治疗方式,只有在疾病转移时才使用化疗。